This HTML5 document contains 62 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n17http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/kegg-drug/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n19http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/drugbank/
n21http://linked.opendata.cz/resource/mesh/concept/
n18http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/chemspider/
n16http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/wikipedia/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/pharmgkb/
owlhttp://www.w3.org/2002/07/owl#
n20http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n15http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/kegg-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/bindingdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB00173/identifier/pubchem-substance/

Statements

Subject Item
n2:DB00173
rdf:type
n3:Drug
n3:description
A purine base and a fundamental unit of adenine nucleotides. [PubChem]
n3:group
nutraceutical approved
n3:indication
For nutritional supplementation, also for treating dietary shortage or imbalance
owl:sameAs
n6:DB00173 n16:DB00173
dcterms:title
Adenine
adms:identifier
n8:33218 n9:16708 n10:Adenine n11:PA448048 n12:46507319 n13:ADE n14:190 n15:C00147 n17:D00034 n18:185 n19:DB00173
n3:mechanismOfAction
Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose, and it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between reactions. In older literature, adenine was sometimes called Vitamin B4Not Available
n3:synonym
A Ade Vitamin B4 ADENINE 6-Aminopurine Adenin
n3:synthesisReference
Eiichi Yonemitsu, Tomiya Isshiki, Yasuhiko Kijima, "Process for preparing adenine." U.S. Patent US4059582, issued March, 1964.
n20:hasConcept
n21:M0000347
n3:IUPAC-Name
n4:271B50AD-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B50B3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B50B2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B50AF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B50B0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B50B1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B50AB-363D-11E5-9242-09173F13E4C5 n4:271B50C3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B50A9-363D-11E5-9242-09173F13E4C5 n4:271B50AC-363D-11E5-9242-09173F13E4C5 n4:271B50C5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B50AA-363D-11E5-9242-09173F13E4C5 n4:271B50C6-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B50C7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B50B9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B50BA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B50B4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B50B5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B50B7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B50B6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B50B8-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
73-24-5
n3:category
n3:Bioavailability
n4:271B50BF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B50C1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B50C2-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B50C4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B50BE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B50BD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B50C0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B50AE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B50BB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B50BC-363D-11E5-9242-09173F13E4C5